Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

ICP-MS Analysis Of Lanthanide-doped Nanoparticles As A Non-radiative, Multiplex Approach To Quantify Biodistribution And Blood Clearance.

S. Crayton, Drew R. Elias, A. Al Zaki, Zhiliang Cheng, A. Tsourkas
Published 2012 · Materials Science, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Recent advances in material science and chemistry have led to the development of nanoparticles with diverse physicochemical properties, e.g. size, charge, shape, and surface chemistry. Evaluating which physicochemical properties are best for imaging and therapeutic studies is challenging not only because of the multitude of samples to evaluate, but also because of the large experimental variability associated with in vivo studies (e.g. differences in tumor size, injected dose, subject weight, etc.). To address this issue, we have developed a lanthanide-doped nanoparticle system and analytical method that allows for the quantitative comparison of multiple nanoparticle compositions simultaneously. Specifically, superparamagnetic iron oxide (SPIO) with a range of different sizes and charges were synthesized, each with a unique lanthanide dopant. Following the simultaneous injection of the various SPIO compositions into tumor-bearing mice, inductively coupled plasma mass spectroscopy (ICP-MS) was used to quantitatively and orthogonally assess the concentration of each SPIO composition in serial blood samples and the resected tumor and organs. The method proved generalizable to other nanoparticle platforms, including dendrimers, liposomes, and polymersomes. This approach provides a simple, cost-effective, and non-radiative method to quantitatively compare tumor localization, biodistribution, and blood clearance of more than 10 nanoparticle compositions simultaneously, removing subject-to-subject variability.
This paper references
Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems
P. Karmali (2011)
MR imaging of phagocytosis in experimental gliomas.
C. Zimmer (1995)
Endotoxin reduces specific pulmonary uptake of radiolabeled monoclonal antibody to angiotensin-converting enzyme.
V. Muzykantov (1991)
3.318 – Molecular Imaging
S. Crayton (2011)
Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores.
Hisataka Kobayashi (2003)
Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery (review)
R. B. Huang (2010)
Human transferrin receptor gene as a marker gene for MR imaging.
A. Moore (2001)
Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging.
D. Tomalia (2007)
Particle size-dependent organ distribution of gold nanoparticles after intravenous administration.
W. D. de Jong (2008)
Biological approaches to the controlled delivery of drugs: a critical review.
M. Poznansky (1984)
Improved delineation of human brain tumors on MR images using a long‐circulating, superparamagnetic iron oxide agent
W. S. Enochs (1999)
Engineering Nanocarriers for siRNA Delivery.
S. J. Tan (2011)
Size, charge and concentration dependent uptake of iron oxide particles by non-phagocytic cells.
D. Thorek (2008)
Recent progress in the therapeutic applications of nanotechnology
Melani A Solomon (2011)
Advances in the field of nanooncology
K. Jain (2010)
Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model.
A. Moore (2000)
Nanotechnology and MRI contrast enhancement.
Michael L Matson (2010)
Biodistribution of dual radiolabeled lipidic nanocapsules in the rat using scintigraphy and gamma counting.
A. Cahouet (2002)
Innovations in avoiding particle clearance from blood by Kupffer cells: cause for reflection.
S. Moghimi (1994)
A study of the nucleation and growth processes in the synthesis of colloidal gold
J. Turkevich (1951)
Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.
P. Aggarwal (2009)
Engineering nanocarriers for siRNA delivery. Small 2011;7:841e56
SJ Tan (2011)
Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution.
C. Chouly (1996)
Nanoparticle PEGylation for imaging and therapy.
J. Jokerst (2011)
Nanotechnology for the biologist
S. Mcneil (2005)
Mediating tumor targeting efficiency of nanoparticles through design.
Steven D. Perrault (2009)
Long-circulating and target-specific nanoparticles: theory to practice.
S. Moghimi (2001)
Review of the State-of-the-Art of Laser Ablation Inductively Coupled Plasma Mass Spectrometry
J. Koch (2011)
Tumor Cell Endocytosis Imaging Facilitates Delineation of the Glioma–Brain Interface
C. Zimmer (1997)
Nanoparticles in Biological Systems
W. Stark (2011)
Superparamagnetic Iron Oxide Nanoparticle Probes for Molecular Imaging
D. Thorek (2005)
Pharmacokinetics and enhancement patterns of macromolecular MR contrast agents with various sizes of polyamidoamine dendrimer cores
N. Sato (2001)
Using laser ablation/inductively coupled plasma mass spectrometry to bioimage multiple elements in mouse tumors after hyperthermia
Yi-Kong Hsieh (2011)

This paper is referenced by
Subtumoral analysis of PRINT nanoparticle distribution reveals targeting variation based on cellular and particle properties.
L. E. Roode (2016)
Nanocellulose and Nanogels as Modern Drug Delivery Systems
M. Moscovici (2017)
Maximizing dopant photoluminescence in co-doped semiconductor nanoparticles for multiplex assays by tuning inter dopant electronic interactions: Synthetic co-doping or physical mixing of singly doped moieties?
A. Chakraborty (2018)
Nanoparticle Biokinetics in Mice and Nonhuman Primates.
P. Chiarelli (2017)
In vivo covalent cross-linking of photon-converted rare-earth nanostructures for tumour localization and theranostics
Xiangzhao Ai (2016)
Metal/dye-doped core-shell silica nanoparticles for potential use in bioassay
J. A. Ko (2013)
Europium doping of superparamagnetic iron oxide nanoparticles enables their detection by fluorescence microscopy and for quantitative analytics.
Yuske Kobayashi (2017)
Metabolomic profiling of neoplastic lesions in mice.
Xiaojie Lu (2014)
Multicore magnetic nanoparticles (MMNPs) doped with Cs and FITC for the determination of biomarker in serum using ICP-MS.
Jungaa Ko (2014)
Role of mass spectrometry in the development and medicinal implementation of metal-based nanoparticles
A. Timerbaev (2015)
Complementary approaches for the evaluation of biocompatibility of 90Y-labeled superparamagnetic citric acid (Fe,Er)3O4 coated nanoparticles.
B. Antic (2017)
Biodegradable polydisulfide dendrimer nanoclusters as MRI contrast agents.
Ching-Hui Huang (2012)
In vivo covalent cross-linking of photon-converted rare-earth nanostructures for tumour localization and theranostics
Xiangzhao Ai (2016)
Extension of in vivo half-life of biologically active molecules by XTEN protein polymers.
V. Podust (2016)
Preparation of PEGylated Iodine‐Loaded Nanoparticles via Polymer‐Directed Self‐Assembly
C. Tang (2018)
Comparative acute intravenous toxicity study of triple polymer-layered magnetic nanoparticles with bare magnetic nanoparticles in Swiss albino mice
Anas Ahmad (2020)
Bio-distribution and in vivo/in vitro toxicity profile of PEGylated polymer capsules encapsulating LaVO4:Tb3+ nanoparticles for bioimaging applications
C. R. Dhanya (2016)
Therapeutic targeting in nanomedicine: the future lies in recombinant antibodies.
G. Pietersz (2017)
Effect of ligand density, receptor density, and nanoparticle size on cell targeting.
Drew R. Elias (2013)
Magnetometry based method for investigation of nanoparticle clearance from circulation in a liver perfusion model.
I. V. Zelepukin (2019)
Fast processes of nanoparticle blood clearance: Comprehensive study.
I. V. Zelepukin (2020)
Using anti-poly(ethylene glycol) bioparticles for the quantitation of PEGylated nanoparticles
Yuan-Chin Hsieh (2016)
Safety Assessment of Nanoprobes
Y. Liu (2017)
Simultaneous quantification of tumor uptake for targeted and nontargeted liposomes and their encapsulated contents by ICPMS.
Zhiliang Cheng (2012)
Optical imaging to trace near infrared fluorescent zinc oxide nanoparticles following oral exposure
Changmoon Lee (2012)
Sensing Lanthanide Metal Content in Biological Tissues with Magnetic Resonance Spectroscopy
Dina V. Hingorani (2013)
High-Speed, Integrated Ablation Cell and Dual Concentric Injector Plasma Torch for Laser Ablation-Inductively Coupled Plasma Mass Spectrometry.
David N. Douglas (2015)
Considerations of inductively coupled plasma mass spectrometry techniques for characterizing the dissolution of metal-based nanomaterials in biological tissues
Cheng-Kuan Su (2015)
Biocompatible Polymer Nanoformulation To Improve the Release and Safety of a Drug Mimic Molecule Detectable via ICP-MS.
R. Ferrari (2017)
Nanogel Carrier Design for Targeted Drug Delivery.
D. Eckmann (2014)
Characterization techniques for nanoparticles: comparison and complementarity upon studying nanoparticle properties.
S. Mourdikoudis (2018)
Quantitative Comparison of Tumor Delivery for Multiple Targeted Nanoparticles Simultaneously by Multiplex ICP-MS
A. Elias (2014)
See more
Semantic Scholar Logo Some data provided by SemanticScholar